Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of A8G6 Nasal Spray in Healthy Subjects
NCT06127498Phase 1Unknown
- Sponsor
- The 2nd Affiliated Hospital of Chongqing Medical University
- Start
- May 2022
- Primary completion
- Dec 2023
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in coronavirus disease 2019 (COVID-19) comparing A8G6 Nasal Spray with Placebo (2 arms). Primary endpoints: Vital Signs, Laboratory Tests and 2 more. Status: unknown.
02
Drugs
A8G6
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT06127498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06127498.